AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $5.38
- 52-wk low
- $3.49
- Prev close
- $4.38
- Mkt cap
- $957.6M
- P/E
- 6.1x
- Fwd P/E
- 10.3x
Smart money
Earnings
Earnings landed in line with what analysts expected.
Financials
What it sold, what it cost, what was left.
Jun 2025Sep 2025Dec 2025Mar 2026
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $10.7M | $529.0K | $1.1M | $179.1M |
| Cost of what it sold | $11.0K | $11.0K | $11.0K | $11.0K |
| Gross profit | $10.7M | $518.0K | $1.0M | $179.1M |
| What it spent | ||||
| Research and development | $5.5M | $5.8M | $5.0M | $4.1M |
| Sales and admin | $3.3M | $3.0M | $3.7M | $5.9M |
| Other operating costs | $425.0K | — | — | — |
| Total operating expenses | $9.3M | $8.8M | $8.7M | $10.0M |
| What was left | ||||
| Operating profit | $1.5M | -$8.3M | -$7.6M | $169.1M |
| Interest on debt | $28.0K | $23.0K | $18.0K | $17.0K |
| Profit before tax | $2.5M | -$7.7M | -$3.8M | $169.7M |
| Net profit | $2.5M | -$7.7M | -$3.8M | $169.7M |
| EBITDA | $2.6M | -$7.7M | -$3.7M | $169.7M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
9 articles · 7 days
Coverage is mixed
Tone of tracked coverage
Arbutus Biopharma (NASDAQ:ABUS) Cut to Hold at Wall Street Zen
NeutralAug 15Form 8K Arbutus Biopharma Corp For: 12 August By Investing.com
NeutralAug 13Arbutus Biopharma (ABUS) Stock Profit Surge Leaves Durability Questions Open
NeutralAug 12
